Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists: An executive summary

被引:0
作者
Sherman, Elizabeth M. [1 ,2 ]
Agwu, Allison L. [3 ]
Ambrosioni, Juan [4 ,5 ,6 ,7 ,8 ]
Behrens, Georg M. N. [9 ,10 ,11 ]
Chu, Carolyn [12 ]
Collins, Lauren F. [13 ]
Jimenez, Humberto R. [14 ,15 ]
Koren, David E. [16 ]
McGorman, Leslie [17 ,28 ]
Nguyen, Nancy N. [18 ]
Nicol, Melanie R. [19 ]
Pandit, Neha Sheth [20 ]
Pierre, Natacha [21 ]
Scarsi, Kimberly K. [22 ]
Spinner, Gary F. [23 ]
Tseng, Alice [24 ,25 ]
Young, Jeremy D. [26 ]
Badowski, Melissa E. [27 ]
机构
[1] Nova Southeastern Univ, Barry & Judy Silverman Coll Pharm, Ft Lauderdale, FL 33328 USA
[2] Mem Healthcare Syst, Div Infect Dis, Hollywood, FL USA
[3] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD USA
[4] Hosp Clin Barcelona, HIV Unit, Barcelona, Spain
[5] Hosp Clin Barcelona, Infect Dis Serv, Barcelona, Spain
[6] Fundacio Recerca Clin Barcelona IDIBAPS, Barcelona, Spain
[7] Univ Barcelona, Barcelona, Spain
[8] Inst Salud Carlos III, CIBERINFEC, Madrid, Spain
[9] Hannover Med Sch, Dept Rheumatol & Immunol, Hannover, Germany
[10] German Ctr Infect Res DZ, Partner Site Hannover Braunschweig, Hannover, Germany
[11] Hannover Med Sch, Ctr Individualized Infect Med CiiM, Hannover, Germany
[12] Univ Calif San Francisco, San Francisco, CA USA
[13] Grady Ponce de Leon Ctr, Emory Sch Med, Div Infect Dis, Atlanta, GA USA
[14] Rutgers State Univ, Ernest Mario Sch Pharm, Piscataway, NJ USA
[15] St Josephs Univ, Comprehens Care Ctr, Med Ctr, Paterson, NJ USA
[16] Temple Univ Hlth Syst, Philadelphia, PA USA
[17] Amer Acad HIV Med, Washington, DC USA
[18] Univ Pacific, Thomas J Long Sch Pharm, Stockton, CA USA
[19] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN USA
[20] Univ Maryland Baltimore, Sch Pharm, Dept Practice Sci & Hlth Outcomes Res, Baltimore, MD USA
[21] Univ Illinois, Coll Nursing, Dept Populat Hlth Nursing Sci, Chicago, IL USA
[22] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharm Practice & Sci, Omaha, NE USA
[23] Southwest Community Hlth Ctr, Bridgeport, CT USA
[24] Univ Hlth Network, Immunodeficiency Clin, Toronto, ON, Canada
[25] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada
[26] Ohio State Univ, Wexner Med Ctr, Div Infect Dis, Columbus, OH USA
[27] Univ Illinois, Coll Pharm, Chicago, IL USA
[28] AIDS United, Washington, DC USA
来源
PHARMACOTHERAPY | 2024年 / 44卷 / 07期
关键词
antiretrovirals; HIV; long acting; pre-exposure prophylaxis; prevention; treatment; ANTITUMOR NECROSIS FACTOR; SERIOUS BACTERIAL-INFECTIONS; PROPENSITY SCORE METHODS; RHEUMATOID-ARTHRITIS; RISK; HOSPITALIZATION; THERAPY; SURVIVAL;
D O I
10.1002/phar.2921
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Five long-acting (LA) antiretrovirals (ARVs) are currently available in a limited number of countries worldwide for HIV-1 prevention or treatment - cabotegravir, rilpivirine, lenacapavir, ibalizumab, and dapivirine. Implementing use of LA ARVs in routine clinical practice requires significant changes to the current framework of HIV-1 prevention, treatment, and service provision. Given the novelty, complexity, and interdisciplinary requirements of safe and optimal use of LA ARVs, consensus recommendations on the use of LA ARVs will assist clinicians in optimizing use of these agents. The purpose of these recommendations is to provide guidance for the clinical use of LA ARVs for HIV-1 treatment and prevention. In addition, future areas of research are identified and discussed.
引用
收藏
页码:488 / 493
页数:6
相关论文
共 44 条
[11]   Frequency of infection in patients with rheumatoid arthritis compared with controls - A population-based study [J].
Doran, MF ;
Crowson, CS ;
Pond, GR ;
O'Fallon, WM ;
Gabriel, SE .
ARTHRITIS AND RHEUMATISM, 2002, 46 (09) :2287-2293
[12]   The effectiveness of anti-tumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis - A population-based study [J].
Finckh, A ;
Simard, JF ;
Duryea, J ;
Liang, MH ;
Huang, J ;
Daneel, S ;
Forster, A ;
Gabay, C ;
Guerne, PA .
ARTHRITIS AND RHEUMATISM, 2006, 54 (01) :54-59
[13]   2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis [J].
Fraenkel, Liana ;
Bathon, Joan M. ;
England, Bryant R. ;
St Clair, E. William ;
Arayssi, Thurayya ;
Carandang, Kristine ;
Deane, Kevin D. ;
Genovese, Mark ;
Huston, Kent Kwas ;
Kerr, Gail ;
Kremer, Joel ;
Nakamura, Mary C. ;
Russell, Linda A. ;
Singh, Jasvinder A. ;
Smith, Benjamin J. ;
Sparks, Jeffrey A. ;
Venkatachalam, Shilpa ;
Weinblatt, Michael E. ;
Al-Gibbawi, Mounir ;
Baker, Joshua F. ;
Barbour, Kamil E. ;
Barton, Jennifer L. ;
Cappelli, Laura ;
Chamseddine, Fatimah ;
George, Michael ;
Johnson, Sindhu R. ;
Kahale, Lara ;
Karam, Basil S. ;
Khamis, Assem M. ;
Navarro-Millan, Iris ;
Mirza, Reza ;
Schwab, Pascale ;
Singh, Namrata ;
Turgunbaev, Marat ;
Turner, Amy S. ;
Yaacoub, Sally ;
Akl, Elie A. .
ARTHRITIS & RHEUMATOLOGY, 2021, 73 (07) :1108-1123
[14]   Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis A Cohort Study [J].
George, Michael D. ;
Baker, Joshua F. ;
Winthrop, Kevin ;
Hsu, Jesse Y. ;
Wu, Qufei ;
Chen, Lang ;
Xie, Fenglong ;
Yun, Huifeng ;
Curtis, Jeffrey R. .
ANNALS OF INTERNAL MEDICINE, 2020, 173 (11) :870-+
[15]   Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases [J].
Grijalva, Carlos G. ;
Chen, Lang ;
Delzell, Elizabeth ;
Baddley, John W. ;
Beukelman, Timothy ;
Winthrop, Kevin L. ;
Griffin, Marie R. ;
Herrinton, Lisa J. ;
Liu, Liyan ;
Ouellet-Hellstrom, Rita ;
Patkar, Nivedita M. ;
Solomon, Daniel H. ;
Lewis, James D. ;
Xie, Fenglong ;
Saag, Kenneth G. ;
Curtis, Jeffrey R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (21) :2331-2339
[16]   Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs: Evaluation of data from a Japanese claims database [J].
Harigai, Masayoshi ;
Fujii, Takao ;
Sakai, Ryoko ;
Igarashi, Ataru ;
Shoji, Ayako ;
Yamaguchi, Hiroko ;
Iwasaki, Katsuhiko ;
Makishima, Misako ;
Yoshida, Amika ;
Okada, Norihiro ;
Yamashita, Katsuhisa ;
Kawahito, Yutaka .
MODERN RHEUMATOLOGY, 2024, 34 (02) :287-296
[17]   Prevalence of Sjogren's syndrome associated with rheumatoid arthritis in the USA: an observational study from the Corrona registry [J].
Harrold, Leslie R. ;
Shan, Ying ;
Rebello, Sabrina ;
Kramer, Neil ;
Connolly, Sean E. ;
Alemao, Evo ;
Kelly, Sheila ;
Kremer, Joel M. ;
Rosenstein, Elliot D. .
CLINICAL RHEUMATOLOGY, 2020, 39 (06) :1899-1905
[18]   Prescribing Trends of Biologic Disease-Modifying Anti-rheumatic Drugs Using a Claims Database from 6 Million People in Japan [J].
Hirata, Atsushi ;
Ota, Ryosuke ;
Hata, Takeo ;
Hamada, Takeshi ;
Nishihara, Masami ;
Uchiyama, Kazuhisa ;
Katsumata, Takahiro .
CLINICAL DRUG INVESTIGATION, 2021, 41 (11) :967-974
[19]   Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication [J].
Kawahito, Yutaka ;
Morinobu, Akio ;
Kaneko, Yuko ;
Kohno, Masataka ;
Hirata, Shintaro ;
Kishimoto, Mitsumasa ;
Seto, Yohei ;
Sugihara, Takahiko ;
Tanaka, Eiichi ;
Ito, Hiromu ;
Kojima, Toshihisa ;
Matsushita, Isao ;
Nishida, Keiichiro ;
Mori, Masaaki ;
Murashima, Atsuko ;
Yamanaka, Hisashi ;
Nakayama, Takeo ;
Kojima, Masayo ;
Harigai, Masayoshi .
MODERN RHEUMATOLOGY, 2023, 33 (01) :21-35
[20]   TNF-α Antagonist Use and Risk of Hospitalization for Infection in a National Cohort of Veterans With Rheumatoid Arthritis [J].
Lane, Michael A. ;
McDonald, Jay R. ;
Zeringue, Angelique L. ;
Caplan, Liron ;
Curtis, Jeffrey R. ;
Ranganathan, Prabha ;
Eisen, Seth A. .
MEDICINE, 2011, 90 (02) :139-145